← Back to search results

plannedFind a Tender · planning

Microbiology Serology Testing

Buyer: NHS Blood & Transplant →

BuyerNHS Blood & Transplant
Statusplanned
DeadlineNot published
Value£6,500,000
Published28 Jan 2021

What is being bought

This notice is related to, but supersedes, OJEU notice: 2020/S 198-481270, which requested that potential bidders of NHSBT’s tender for microbiology serology screening/testing of blood and non-blood donations register their interest such that the necessary Kit Evaluation Group (KEG) preparatory work can be completed.

Delivery location

UK

Categories

Diagnostic systems 33124110Diagnostic supplies 33124130Diagnostic kits 33141625Laboratory reagents 33696500Microbiological cultures 33698100Automation system 48921000Pathology services 85111800Laboratory services 71900000

Lot details

Lot 1

NHSBT currently has a formal contractual arrangement in place for the microbiology serological screening/testing of blood and non-blood donations. The contract includes the supply of the mandatory and selective serology assays, consumables, instrumentation, uninterruptable power supply’s and software required for result management and interface(s) with host systems; including servers to support the IT infrastructure. Mandatory testing is undertaken on all blood donations. The assays required include Hepatitis B (HBsAg), Human immunodeficiency virus (HIV 1&2 Ab/Ag), Hepatitis C (anti-HCV) and syphilis antibodies and these tests are undertaken on high throughput automated equipment. Additional testing is also undertaken on select donations. These include testing for human T- lymphotropic virus (anti-HTLV), cytomegalovirus (anti-CMV), malarial antibody (anti-malaria), Hepatitis B antibodies (anti-HBc & anti-HBs) and Trypanosome cruzi (anti-T. cruzi). NHSBT also undertakes some alternative testing for blood donors when required. Additional assays for the following markers; HBsAg, anti-HIV1&2 Ag/Ab, anti-HCV, anti-syphilis and anti-HTLV would be required for approximately 3000 alternative tests per year, which are made up of a combination of these markers. Please note: Assays/test systems KEG approval of assays/systems must be obtained prior to tender. See OJEU notice: 2020/S 198-481270 for more information. There is a requirement for automated instrumentation to enable high throughput testing of mandatory and discretionary testing for blood and non-blood donors, archiving and long-term storage of plasma samples as part of this contract. Instrumentation for sample sorting is also for consideration. The NHSBT Microbiology Serology Testing contract has an annual value of circa £6.5m (Ex VAT) and approximately 1.6m donations are tested per annum across two Testing sites. It is NHSBT's intention to engage with the market to gather detailed information about the market's capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier engagement days are due two-fold with a Webinar Monday 22nd February 2021 for NHSBT to present the project (a copy of the presentation will be sent ahead of the Webinar) and individual supplier presentation days to be held on the 24th and 25th of February 2021. If you are interested in this requirement, please email jess.allen@nhsbt.nhs.uk by no later than 1200 hours on Monday 8th February 2021. If you do not respond by this date your organisation will not be excluded from taking part in the forthcoming tender. A subsequent Contract Notice relating to the future tender will be submitted for publication at the same time as the Invitation To Tender (ITT) is issued.

Statusplanned

What is included

ItemCategoryQuantity
1Diagnostic systems, Diagnostic supplies, Diagnostic kits, Laboratory reagents, Microbiological cultures, Automation system, Pathology servicesNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Diagnostic systems (33124110); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,8542 median · 122.5 average (2,278 of 4,854 with a bid count)5.8 average (2,724 of 4,854 with named award suppliers)Not published
Same buyer141 median · 2.7 average (6 of 14 with a bid count)1.5 average (6 of 14 with named award suppliers)Not published
Delivery region: UK1,4337 median · 323.1 average (652 of 1,433 with a bid count)10 average (788 of 1,433 with named award suppliers)Not published
Similar published value (0.5×–2×)25424 median · 36 average (5 of 254 with a bid count)6.8 average (5 of 254 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-028e59
Latest release ID001795-2021
Latest release timestampThu Jan 28 2021 22:56:10 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanned
Procurement methodNot published
Procurement method detailsNot published
Main procurement categoryservices
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender value£6,500,000
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
28 Jan 2021planning001795-2021

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "001795-2021",
  "tag": [
    "planning"
  ],
  "date": "2021-01-28T22:56:10Z",
  "ocid": "ocds-h6vhtk-028e59",
  "buyer": {
    "id": "GB-FTS-1395",
    "name": "NHS Blood & Transplant"
  },
  "tender": {
    "id": "NHSBT1475",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHSBT currently has a formal contractual arrangement in place for the microbiology serological screening/testing of blood and non-blood donations. The contract includes the supply of the mandatory and selective serology assays, consumables, instrumentation, uninterruptable power supply’s and software required for result management and interface(s) with host systems; including servers to support the IT infrastructure. \nMandatory testing is undertaken on all blood donations. The assays required include Hepatitis B (HBsAg), Human immunodeficiency virus (HIV 1&2 Ab/Ag), Hepatitis C (anti-HCV) and syphilis antibodies and these tests are undertaken on high throughput automated equipment. Additional testing is also undertaken on select donations. These include testing for human T- lymphotropic virus (anti-HTLV), cytomegalovirus (anti-CMV), malarial antibody (anti-malaria), Hepatitis B antibodies (anti-HBc & anti-HBs) and Trypanosome cruzi (anti-T. cruzi). NHSBT also undertakes some alternative testing for blood donors when required. Additional assays for the following markers; HBsAg, anti-HIV1&2 Ag/Ab, anti-HCV, anti-syphilis and anti-HTLV would be required for approximately 3000 alternative tests per year, which are made up of a combination of these markers. Please note: Assays/test systems KEG approval of assays/systems must be obtained prior to tender. See OJEU notice: 2020/S 198-481270 for more information.\nThere is a requirement for automated instrumentation to enable high throughput testing of mandatory and discretionary testing for blood and non-blood donors, archiving and long-term storage of plasma samples as part of this contract.   Instrumentation for sample sorting is also for consideration.\nThe NHSBT Microbiology Serology Testing contract has an annual value of circa £6.5m (Ex VAT) and approximately 1.6m donations are tested per annum across two Testing sites. \nIt is NHSBT's intention to engage with the market to gather detailed information about the market's capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier engagement days are due two-fold with a Webinar Monday 22nd February 2021 for NHSBT to present the project (a copy of the presentation will be sent ahead of the Webinar) and individual supplier presentation days to be held on the 24th and 25th of February 2021. If you are interested in this requirement, please email jess.allen@nhsbt.nhs.uk by no later than 1200 hours on Monday 8th February 2021. If you do not respond by this date your organisation will not be excluded from taking part in the forthcoming tender.\nA subsequent Contract Notice relating to the future tender will be submitted for publication at the same time as the Invitation To Tender (ITT) is issued."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "Filton and Manchester"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33124110",
            "scheme": "CPV",
            "description": "Diagnostic systems"
          },
          {
            "id": "33124130",
            "scheme": "CPV",
            "description": "Diagnostic supplies"
          },
          {
            "id": "33141625",
            "scheme": "CPV",
            "description": "Diagnostic kits"
          },
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          },
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "85111800",
            "scheme": "CPV",
            "description": "Pathology services"
          }
        ]
      }
    ],
    "title": "Microbiology Serology Testing",
    "value": {
      "amount": 6500000,
      "currency": "GBP"
    },
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This notice is related to, but supersedes, OJEU notice: 2020/S 198-481270, which requested that potential bidders of NHSBT’s tender for microbiology serology screening/testing of blood and non-blood donations register their interest such that the necessary Kit Evaluation Group (KEG) preparatory work can be completed.",
    "communication": {
      "futureNoticeDate": "2021-09-13T00:00:00+01:00"
    },
    "classification": {
      "id": "71900000",
      "scheme": "CPV",
      "description": "Laboratory services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-1395",
      "name": "NHS Blood & Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UK",
        "locality": "Filton, Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood & Transplant"
      },
      "contactPoint": {
        "email": "Jess.Allen@nhsbt.nhs.uk",
        "telephone": "+44 1179217253"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
28 Jan 2021 · 001795-2021 · planning
{
  "id": "001795-2021",
  "tag": [
    "planning"
  ],
  "date": "2021-01-28T22:56:10Z",
  "ocid": "ocds-h6vhtk-028e59",
  "buyer": {
    "id": "GB-FTS-1395",
    "name": "NHS Blood & Transplant"
  },
  "tender": {
    "id": "NHSBT1475",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHSBT currently has a formal contractual arrangement in place for the microbiology serological screening/testing of blood and non-blood donations. The contract includes the supply of the mandatory and selective serology assays, consumables, instrumentation, uninterruptable power supply’s and software required for result management and interface(s) with host systems; including servers to support the IT infrastructure. \nMandatory testing is undertaken on all blood donations. The assays required include Hepatitis B (HBsAg), Human immunodeficiency virus (HIV 1&2 Ab/Ag), Hepatitis C (anti-HCV) and syphilis antibodies and these tests are undertaken on high throughput automated equipment. Additional testing is also undertaken on select donations. These include testing for human T- lymphotropic virus (anti-HTLV), cytomegalovirus (anti-CMV), malarial antibody (anti-malaria), Hepatitis B antibodies (anti-HBc & anti-HBs) and Trypanosome cruzi (anti-T. cruzi). NHSBT also undertakes some alternative testing for blood donors when required. Additional assays for the following markers; HBsAg, anti-HIV1&2 Ag/Ab, anti-HCV, anti-syphilis and anti-HTLV would be required for approximately 3000 alternative tests per year, which are made up of a combination of these markers. Please note: Assays/test systems KEG approval of assays/systems must be obtained prior to tender. See OJEU notice: 2020/S 198-481270 for more information.\nThere is a requirement for automated instrumentation to enable high throughput testing of mandatory and discretionary testing for blood and non-blood donors, archiving and long-term storage of plasma samples as part of this contract.   Instrumentation for sample sorting is also for consideration.\nThe NHSBT Microbiology Serology Testing contract has an annual value of circa £6.5m (Ex VAT) and approximately 1.6m donations are tested per annum across two Testing sites. \nIt is NHSBT's intention to engage with the market to gather detailed information about the market's capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier engagement days are due two-fold with a Webinar Monday 22nd February 2021 for NHSBT to present the project (a copy of the presentation will be sent ahead of the Webinar) and individual supplier presentation days to be held on the 24th and 25th of February 2021. If you are interested in this requirement, please email jess.allen@nhsbt.nhs.uk by no later than 1200 hours on Monday 8th February 2021. If you do not respond by this date your organisation will not be excluded from taking part in the forthcoming tender.\nA subsequent Contract Notice relating to the future tender will be submitted for publication at the same time as the Invitation To Tender (ITT) is issued."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "Filton and Manchester"
        },
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "33124110",
            "scheme": "CPV",
            "description": "Diagnostic systems"
          },
          {
            "id": "33124130",
            "scheme": "CPV",
            "description": "Diagnostic supplies"
          },
          {
            "id": "33141625",
            "scheme": "CPV",
            "description": "Diagnostic kits"
          },
          {
            "id": "33696500",
            "scheme": "CPV",
            "description": "Laboratory reagents"
          },
          {
            "id": "33698100",
            "scheme": "CPV",
            "description": "Microbiological cultures"
          },
          {
            "id": "48921000",
            "scheme": "CPV",
            "description": "Automation system"
          },
          {
            "id": "85111800",
            "scheme": "CPV",
            "description": "Pathology services"
          }
        ]
      }
    ],
    "title": "Microbiology Serology Testing",
    "value": {
      "amount": 6500000,
      "currency": "GBP"
    },
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This notice is related to, but supersedes, OJEU notice: 2020/S 198-481270, which requested that potential bidders of NHSBT’s tender for microbiology serology screening/testing of blood and non-blood donations register their interest such that the necessary Kit Evaluation Group (KEG) preparatory work can be completed.",
    "communication": {
      "futureNoticeDate": "2021-09-13T00:00:00+01:00"
    },
    "classification": {
      "id": "71900000",
      "scheme": "CPV",
      "description": "Laboratory services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-1395",
      "name": "NHS Blood & Transplant",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UK",
        "locality": "Filton, Bristol",
        "postalCode": "BS34 7QH",
        "countryName": "United Kingdom",
        "streetAddress": "North Bristol Park"
      },
      "details": {
        "url": "https://www.nhsbt.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS Blood & Transplant"
      },
      "contactPoint": {
        "email": "Jess.Allen@nhsbt.nhs.uk",
        "telephone": "+44 1179217253"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}